CRDF - Cardiff Oncology, Inc.
IEX Last Trade
4.3
-0.050 -1.163%
Share volume: 26,574
Last Updated: Thu 26 Dec 2024 08:30:10 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$4.35
-0.05
-1.15%
Summary score
22%
Profitability
25%
Dept financing
8%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-46.79%
Return on assets
-26.82%
Return on sales
-3628.01%
Return on invested capital
283.46%
Total debt ratio
34.13%
Debt ratio change over timeo
-0.87%
Current Ratio
3.96%
Quick Ratio
0%
Cash Position Ratio
3.64%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-40.43%
Return on assets
-22.52%
Return on sales
0%
Return on invested capital
159.26%
Total debt ratio
30.79%
Debt ratio change over timeo
-0.83%
Current Ratio
4.33%
Quick Ratio
0%
Cash Position Ratio
4.08%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-13.43%
Return on assets
-11.06%
Return on sales
0%
Return on invested capital
107.71%
Total debt ratio
15.03%
Debt ratio change over time
-0.93%
Current Ratio
7.02%
Quick Ratio
0%
Cash Position Ratio
6.69%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-119.34%
Return on assets
-110.57%
Return on sales
-1242.26%
Return on invested capital
2.83%
Total debt ratio
-86.62%
Debt ratio change over time
-0.87%
Current Ratio
0.65%
Quick Ratio
0%
Cash Position Ratio
0.61%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRDF | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -46.79% | -3.65% | 12.3% | 6.42% |
| Return on assets | -26.82% | 3.5% | 3.6% | 5.35% |
| Return on sales | -3628.01% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 283.46% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 60% |
| Total debt ratio | 34.13% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.87% | 224.03% | 6.03% | 1.46% |
| Dept financing | 8% | 50% | 19% | 8% |
| Current Ratio | 4.33% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.08% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 24% | 51% | 56% |
| Short-term ratios | CRDF | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -40.43% | -16.17% | 18.05% | 7.63% |
| Return on assets | -22.52% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 159.26% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 35% | 69% | 63% |
| Total debt ratio | 30.79% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.83% | 851.68% | 10.97% | 0.58% |
| Dept financing | 8% | 50% | 21% | 8% |
| Current Ratio | 4.33% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.08% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 37% | 29% | 54% |